Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$9.82M |
| 2 |
Dollar Tree
DLTR
|
+$8.78M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$7.72M |
| 4 |
Elevance Health
ELV
|
+$7.55M |
| 5 |
Cigna
CI
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$14.8M |
| 2 |
AET
Aetna Inc
AET
|
+$12.6M |
| 3 |
Merck
MRK
|
+$12.6M |
| 4 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$12.6M |
| 5 |
Northrop Grumman
NOC
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.17% |
| 2 | Consumer Discretionary | 17.86% |
| 3 | Industrials | 12.79% |
| 4 | Financials | 9.03% |
| 5 | Technology | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Incyte
INCY
$25.9B
| $253K | 0.02% |
2,670
-5,470
| -67% | -$572K |
|
627
Rigel Pharmaceuticals
RIGL
$857M
| $252K | 0.02% |
+6,479
| New | +$247K |
|
628
Sony
SONY
$140B
| $249K | 0.02% |
+27,720
| New | +$238K |
|
629
Avient
AVNT
$4.1B
| $246K | 0.02% |
+5,645
| New | +$248K |
|
|
TRUE
630
DELISTED
TrueCar
TRUE
| $245K | 0.02% |
21,914
-68,491
| -76% | -$902K |
|
|
OPB
631
DELISTED
Opus Bank Common Stock
OPB
| $245K | 0.02% |
+8,992
| New | +$233K |
|
|
VGR
632
DELISTED
Vector Group Ltd.
VGR
| $244K | 0.02% |
+16,898
| New | +$235K |
|
|
TRVN
633
DELISTED
Trevena, Inc.
TRVN
| $240K | 0.02% |
240
-400
| -63% | -$435K |
|
634
Kimco Realty
KIM
$16.1B
| $239K | 0.02% |
+13,145
| New | +$246K |
|
|
SPLK
635
DELISTED
Splunk Inc
SPLK
| $239K | 0.02% |
2,883
-810
| -22% | -$59.4K |
|
|
GG
636
DELISTED
Goldcorp Inc
GG
| $239K | 0.02% |
+18,685
| New | +$241K |
|
637
W.P. Carey
WPC
$16.2B
| $235K | 0.02% |
+3,482
| New | +$238K |
|
|
SLCA
638
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $235K | 0.02% |
+7,221
| New | +$230K |
|
639
PUT
Bristol-Myers Squibb
BMY
$137B
| $232K | 0.02% |
+100,000
| New | +$6.25M |
|
640
Enbridge
ENB
$110B
| $231K | 0.02% |
+5,909
| New | +$227K |
|
|
BHR
641
Braemar Hotels & Resorts
BHR
$142M
| $230K | 0.02% |
+23,905
| New | +$228K |
|
642
Bank of Hawaii
BOH
$3.06B
| $229K | 0.02% |
2,679
-265
| -9% | -$22.1K |
|
643
Molson Coors Class B
TAP
$8.01B
| $229K | 0.02% |
2,789
-2,403
| -46% | -$194K |
|
644
Eagle Bancorp
EGBN
$861M
| $226K | 0.02% |
+3,896
| New | +$249K |
|
645
Mercury Insurance
MCY
$5.85B
| $226K | 0.02% |
+4,232
| New | +$233K |
|
646
CALL
Tronox
TROX
$888M
| $226K | 0.02% |
+305,900
| New | +$7.46M |
|
647
Albany International
AIN
$1.68B
| $224K | 0.02% |
+3,648
| New | +$220K |
|
648
Banc of California
BANC
$2.95B
| $224K | 0.02% |
+10,874
| New | +$227K |
|
649
Yext
YEXT
$637M
| $224K | 0.02% |
+18,683
| New | +$234K |
|
650
AB InBev
BUD
$155B
| $221K | 0.02% |
1,983
-99,163
| -98% | -$11.7M |
|
Similar funds
Steve Schonfeld's Q4 2017 Portfolio in Review
As of Q4 2017, Steve Schonfeld held 998 positions worth $1.22B, up 12% from $1.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Steve Schonfeld deployed $160M of net new capital in Q4 2017, opening 433 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Aetna Inc, an estimated $12.6M trimmed.
- Steve Schonfeld's largest Q4 2017 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
- Steve Schonfeld added most to Dollar Tree in Q4 2017, an estimated $8.78M increase.
- Steve Schonfeld's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $12.6M.
- Steve Schonfeld fully exited First Data Corporation in Q4 2017, selling an estimated $14.8M.
- Steve Schonfeld's ten largest holdings make up 9.3% of its $1.22B portfolio in Q4 2017.
- Steve Schonfeld opened 433 new positions and closed 273 in Q4 2017.
- Steve Schonfeld's portfolio value rose 12% quarter-over-quarter to $1.22B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.